HK1002019A1 - Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one - Google Patents

Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one

Info

Publication number
HK1002019A1
HK1002019A1 HK98101031A HK98101031A HK1002019A1 HK 1002019 A1 HK1002019 A1 HK 1002019A1 HK 98101031 A HK98101031 A HK 98101031A HK 98101031 A HK98101031 A HK 98101031A HK 1002019 A1 HK1002019 A1 HK 1002019A1
Authority
HK
Hong Kong
Prior art keywords
compound
pregn
hydroxy
methyl
pharmaceutical composition
Prior art date
Application number
HK98101031A
Other languages
English (en)
Inventor
G A J M T Sas
Van E M Doornum
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1002019(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of HK1002019A1 publication Critical patent/HK1002019A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98101031A 1989-03-18 1998-02-11 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one HK1002019A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (1)

Publication Number Publication Date
HK1002019A1 true HK1002019A1 (en) 1998-07-24

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101031A HK1002019A1 (en) 1989-03-18 1998-02-11 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one

Country Status (17)

Country Link
US (1) US5037817A (fi)
EP (1) EP0389035B1 (fi)
JP (2) JP3139709B2 (fi)
KR (1) KR0183401B1 (fi)
AT (1) ATE98490T1 (fi)
AU (1) AU625083B2 (fi)
CA (1) CA2011452C (fi)
DE (1) DE69005165T2 (fi)
DK (1) DK0389035T3 (fi)
ES (1) ES2062292T3 (fi)
FI (1) FI94865C (fi)
HK (1) HK1002019A1 (fi)
IE (1) IE63051B1 (fi)
MX (1) MX9203787A (fi)
NZ (1) NZ232946A (fi)
PT (1) PT93488B (fi)
ZA (1) ZA901674B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180669T1 (de) * 1993-03-05 1999-06-15 Akzo Nobel Nv Verwendung von pregnanderivaten zur behandlung von tumoren
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
IL141850A (en) * 1998-10-16 2005-11-20 Akzo Nobel Nv High purity composition comprising (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-3n-20-yn-3-one
CN101543500A (zh) * 1999-03-18 2009-09-30 基因实验室技术公司 Dhea制剂及方法
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
EP1444247B1 (en) * 2001-10-18 2007-06-13 Norton Healthcare Limited Tibolone formulations
PL371181A1 (en) * 2002-01-22 2005-06-13 Akzo Nobel N.V. Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
MXPA05000824A (es) * 2003-05-23 2005-04-28 Akzo Nobel Nv Forma de dosis farmaceutica de liberacion inmediata que contiene tibolona polimorfa.
EP1883648A1 (en) * 2005-05-23 2008-02-06 Newchem S.p.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) * 2006-02-15 2007-08-22 Oticon A/S Loop antenna for in the ear audio device
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
EP3452019B1 (en) 2016-05-04 2021-06-23 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (fi) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
IE900709L (en) 1990-09-18
FI94865B (fi) 1995-07-31
CA2011452C (en) 1999-05-25
KR0183401B1 (ko) 1999-05-01
MX9203787A (es) 1992-07-01
PT93488A (pt) 1990-11-07
JP3139709B2 (ja) 2001-03-05
ES2062292T3 (es) 1994-12-16
AU5139490A (en) 1990-09-20
EP0389035B1 (en) 1993-12-15
DK0389035T3 (da) 1994-02-14
JP2001139473A (ja) 2001-05-22
US5037817A (en) 1991-08-06
ZA901674B (en) 1990-12-28
IE63051B1 (en) 1995-03-22
FI94865C (fi) 1995-11-10
JPH0347195A (ja) 1991-02-28
CA2011452A1 (en) 1990-09-18
KR900013950A (ko) 1990-10-22
EP0389035A1 (en) 1990-09-26
AU625083B2 (en) 1992-07-02
DE69005165D1 (de) 1994-01-27
NZ232946A (en) 1991-08-27
FI901328A0 (fi) 1990-03-16
PT93488B (pt) 1996-02-29
ATE98490T1 (de) 1994-01-15
DE69005165T2 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
ZA901674B (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure(7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IL102616A0 (en) 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same
HU9200302D0 (en) 1,3-oxatiolane-nucleotide analogues
AU6290090A (en) Bi-or trispecific (fab)3 or (fab)4 conjugates
AR244666A1 (es) Procedimiento para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como analgesicos y relajantes musculares.
EP0538898A3 (en) Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
EP0221728A3 (en) Monosaccharide containing wound healing preparation
AU4717089A (en) N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
HUT65702A (en) 1,2-dithiole-3-thione-derivative-based therapeutical compositions
GB8923820D0 (en) Compound,composition,process and use
OA09192A (en) "Stabilized sulfur dissolving compositions".
EP0352085A3 (en) Electron microscope
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
AU5388090A (en) N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them
AU2831392A (en) Substituted 1, 5-pentanediols and processes for the preparation thereof
AU1117188A (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
AU2403592A (en) 2-aza-2-desamino analogues of 5,8-dideazafolic acid
EP0293633A3 (en) 1,2-di(4-isobutylphenyl)hydrocarbon and its preparation and use as intermediate
GB8812161D0 (en) 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
NZ224728A (en) 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100311